- Home
- UNH vs NVS Comparison
UNH vs NVS Comparison
Compare UNH & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNH | NVS |
|---|---|---|
| Founded | 1977 | 1895 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.9B | 254.8B |
| IPO Year | 1984 | 1991 |
Fundamental Metrics
Financial Performance| Metric | UNH | NVS |
|---|---|---|
| Price | $330.00 | $132.49 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 25 | 3 |
| Target Price | ★ $407.88 | $118.00 |
| AVG Volume (30 Days) | ★ 7.7M | 1.7M |
| Earning Date | 01-15-2026 | 10-28-2025 |
| Dividend Yield | ★ 2.67% | 1.96% |
| EPS Growth | ★ 24.92 | N/A |
| EPS | ★ 19.22 | 7.30 |
| Revenue | ★ $435,159,000,000.00 | $56,372,000,000.00 |
| Revenue This Year | $12.94 | $9.33 |
| Revenue Next Year | $1.55 | $2.75 |
| P/E Ratio | ★ $17.22 | $17.73 |
| Revenue Growth | 10.47 | ★ 12.88 |
| 52 Week Low | $234.60 | $96.06 |
| 52 Week High | $608.99 | $134.24 |
Technical Indicators
Market Signals| Indicator | UNH | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 49.46 | 58.42 |
| Support Level | $322.80 | $132.18 |
| Resistance Level | $341.41 | $134.24 |
| Average True Range (ATR) | 8.63 | 1.72 |
| MACD | 2.34 | 0.46 |
| Stochastic Oscillator | 69.07 | 84.09 |
Price Performance
Historical ComparisonAbout UNH UnitedHealth Group
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.